PHSA 18697 - Sequencing analyzer- Illumina i100 Plus System (Канада - Тендер #71080344)

AI Overview

Provincial Health Services Authority intends to directly award a contract for two Illumina i100 Plus Analyzers for PLMS, BCCDC Public Health Laboratory as a one-time capital equipment purchase.

Basic Information

Reference Number

00004929844

Issuing Organization

Provincial Health Services Authority BC

Solicitation Type

NOI - Notice of Intent (Informal)

Solicitation Number

PHSA 18697

Title

Sequencing analyzer- Illumina i100 Plus System

Source ID

SCRIBE

Details

Location

British Columbia

Purchase Type

Not Stated

Dates

Publication

2026/03/04 08:49:00 AM EST

Closing Date

2026/03/12 06:00:00 PM EDT

Contact Information

Mahsa Sadeghi

mahsa.ardebili@phsa.ca

Description

Notice is hereby given that Provincial Health Services Authority (“PHSA”), intends to directly award a Contract to the following supplier for the purchase of two (2) Illumina i100 Plus Analyzer for PLMS, BCCDC Public Health Laboratory as a one-time capital equipment purchase at an estimated value of $260,000.

Illumina Canada 400-725 Granville Street Vancouver, BC V7Y 1G5

In accordance with applicable trade agreements, PHSA has chosen not to proceed with a competitive process for the following reason:
• the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:
(a) due to an absence of competition for technical reasons

The BCCDC Public Health Laboratory (PHL) currently uses Illumina sequencing platforms for next-generation and whole genome sequencing and intends to replace its two existing Miseq platforms with i100 plus. Only this equipment can meet BCCDC’s technical requirements for the following reasons:
- Assays at BCCDC PHL are validated on these platforms and Bioinformatic pipelines have been developed to analyze and interpret the raw sequence data generated from Illumina sequencers using Illumina sequencing chemistry.
- Interoperability with existing systems is essential to maintain current operations and surge capacity during infectious disease outbreaks.

Transitioning to another supplier would require extensive assay redevelopment, validation, and retraining, introducing significant operational, clinical, and public health risk. Only Illumina can provide i100 plus equipment.

Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Mahsa Sadeghi, by email before 3:00pm Pacific Time, March 12, 2026. PHSA will review any and all issues received by this date and provide due consideration to each objection.

See more Disclaimer All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.

Источник закупки

Перейти

Импорт - Экспорт по стране Канада